Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Point of Care Testing for Infectious Disease Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Point of Care Testing for Infectious Disease Industry
  • 1.7 COVID-19 Impact: Point of Care Testing for Infectious Disease Market Trends

    • 2 Global Point of Care Testing for Infectious Disease Quarterly Market Size Analysis

    • 2.1 Point of Care Testing for Infectious Disease Business Impact Assessment - COVID-19
      • 2.1.1 Global Point of Care Testing for Infectious Disease Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Point of Care Testing for Infectious Disease Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Point of Care Testing for Infectious Disease Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Point of Care Testing for Infectious Disease Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Point of Care Testing for Infectious Disease Market
    • 3.4 Key Players Point of Care Testing for Infectious Disease Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Point of Care Testing for Infectious Disease Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Immunological Test
      • 1.4.2 Pathogen Nucleic Acid Test
    • 4.2 By Type, Global Point of Care Testing for Infectious Disease Market Size, 2019-2021

    5 Impact of Covid-19 on Point of Care Testing for Infectious Disease Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospital
      • 5.5.2 Clinics
      • 5.5.3 Others
    • 5.2 By Application, Global Point of Care Testing for Infectious Disease Market Size, 2019-2021
      • 5.2.1 By Application, Global Point of Care Testing for Infectious Disease Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Abbott
      • 7.1.1 Abbott Business Overview
      • 7.1.2 Abbott Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.1.3 Abbott Point of Care Testing for Infectious Disease Product Introduction
      • 7.1.4 Abbott Response to COVID-19 and Related Developments
    • 7.2 Roche
      • 7.2.1 Roche Business Overview
      • 7.2.2 Roche Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.2.3 Roche Point of Care Testing for Infectious Disease Product Introduction
      • 7.2.4 Roche Response to COVID-19 and Related Developments
    • 7.3 Siemens
      • 7.3.1 Siemens Business Overview
      • 7.3.2 Siemens Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.3.3 Siemens Point of Care Testing for Infectious Disease Product Introduction
      • 7.3.4 Siemens Response to COVID-19 and Related Developments
    • 7.4 Danaher
      • 7.4.1 Danaher Business Overview
      • 7.4.2 Danaher Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.4.3 Danaher Point of Care Testing for Infectious Disease Product Introduction
      • 7.4.4 Danaher Response to COVID-19 and Related Developments
    • 7.5 Becton, Dickinson
      • 7.5.1 Becton, Dickinson Business Overview
      • 7.5.2 Becton, Dickinson Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.5.3 Becton, Dickinson Point of Care Testing for Infectious Disease Product Introduction
      • 7.5.4 Becton, Dickinson Response to COVID-19 and Related Developments
    • 7.6 Johnson & Johnson
      • 7.6.1 Johnson & Johnson Business Overview
      • 7.6.2 Johnson & Johnson Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.6.3 Johnson & Johnson Point of Care Testing for Infectious Disease Product Introduction
      • 7.6.4 Johnson & Johnson Response to COVID-19 and Related Developments
    • 7.7 Instrumentation Laboratory
      • 7.7.1 Instrumentation Laboratory Business Overview
      • 7.7.2 Instrumentation Laboratory Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.7.3 Instrumentation Laboratory Point of Care Testing for Infectious Disease Product Introduction
      • 7.7.4 Instrumentation Laboratory Response to COVID-19 and Related Developments
    • 7.8 PTS Diagnostics
      • 7.8.1 PTS Diagnostics Business Overview
      • 7.8.2 PTS Diagnostics Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.8.3 PTS Diagnostics Point of Care Testing for Infectious Disease Product Introduction
      • 7.8.4 PTS Diagnostics Response to COVID-19 and Related Developments
    • 7.9 Quidel
      • 7.9.1 Quidel Business Overview
      • 7.9.2 Quidel Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.9.3 Quidel Point of Care Testing for Infectious Disease Product Introduction
      • 7.9.4 Quidel Response to COVID-19 and Related Developments
    • 7.10 Sekisui Diagnostics
      • 7.10.1 Sekisui Diagnostics Business Overview
      • 7.10.2 Sekisui Diagnostics Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.10.3 Sekisui Diagnostics Point of Care Testing for Infectious Disease Product Introduction
      • 7.10.4 Sekisui Diagnostics Response to COVID-19 and Related Developments
    • 7.11 Nova
      • 7.11.1 Nova Business Overview
      • 7.11.2 Nova Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.11.3 Nova Point of Care Testing for Infectious Disease Product Introduction
      • 7.11.4 Nova Response to COVID-19 and Related Developments
    • 7.12 EKF Diagnostics
      • 7.12.1 EKF Diagnostics Business Overview
      • 7.12.2 EKF Diagnostics Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.12.3 EKF Diagnostics Point of Care Testing for Infectious Disease Product Introduction
      • 7.12.4 EKF Diagnostics Response to COVID-19 and Related Developments
    • 7.13 AccuBioTech
      • 7.13.1 AccuBioTech Business Overview
      • 7.13.2 AccuBioTech Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.13.3 AccuBioTech Point of Care Testing for Infectious Disease Product Introduction
      • 7.13.4 AccuBioTech Response to COVID-19 and Related Developments
    • 7.14 Trinity Biotech
      • 7.14.1 Trinity Biotech Business Overview
      • 7.14.2 Trinity Biotech Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
      • 7.14.3 Trinity Biotech Point of Care Testing for Infectious Disease Product Introduction
      • 7.14.4 Trinity Biotech Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Point of Care Testing for Infectious Disease, including the following market information:
      Global Point of Care Testing for Infectious Disease Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Point of Care Testing for Infectious Disease Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Point of Care Testing for Infectious Disease Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Point of Care Testing for Infectious Disease Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Abbott, Roche, Siemens, Danaher, Becton, Dickinson, Johnson & Johnson, Instrumentation Laboratory, PTS Diagnostics, Quidel, Sekisui Diagnostics, Nova, EKF Diagnostics, AccuBioTech, Trinity Biotech, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Immunological Test
      Pathogen Nucleic Acid Test

      Based on the Application:
      Hospital
      Clinics
      Others

      Buy now